A study on the efficacy and safety of long‐term adjusted low‐dose gonadotropin‐releasing hormone agonist therapy for uterine fibroids and adenomyosis
GnRH agonist drawback therapy was found to be useful for the long-term conservative treatment of uterine fibroids and adenomyosis. The treatment was safely and inexpensively performed with few adverse events.
Authors
- Yukiko Itaya
- Tomonori Nagai (ORCID: https://orcid.org/0000-0002-2901-4735)
- Shinichiro Yabe (ORCID: https://orcid.org/0000-0003-0249-5177)
- Sumiko Era
- Shigetaka Matsunaga (ORCID: https://orcid.org/0000-0003-2592-9951)
- Kouki Samejima (ORCID: https://orcid.org/0000-0002-1621-720X)
- Yasushi Takai (ORCID: https://orcid.org/0000-0002-3872-8481)
- Akihiko Kikuchi (ORCID: https://orcid.org/0000-0002-5380-1659)
- Tatsuya Narita
- Soichiro Kashiwabara
Institutions
- Social Insurance Saitama Chuo Hospital (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Journal of obstetrics and gynaecology research
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1111/jog.16128
- Citations
- 1
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54